☆ 4.3 Article

Effect of Chlorthalidone, Amlodipine, and Lisinopril on Visit-to-Visit Variability of Blood Pressure: Results From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

JOURNAL OF CLINICAL HYPERTENSION (2014)

期刊

JOURNAL OF CLINICAL HYPERTENSION

卷 16, 期 5, 页码 323-330

出版社

WILEY-BLACKWELL

DOI: 10.1111/jch.12290

关键词

-

类别

Peripheral Vascular Disease

资金

National Heart, Lung, and Blood Institute of the National Institutes of Health [NO1-HC-35130, HHSN268201100036C, R01 HL110993]
Pfizer, Inc.

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Clinical Neurology

Excessive Visit-to-Visit Small and Dense Low-Density Lipoproteins Elevate Cerebral Small Vessel Disease Progression Risk in the Elderly

Weike Liu, Jing Xu, Huajing Song, Chunju Zhang, Yanli Yao, Hua Zhang, Yue-Chun Li, Zhendong Liu

Summary: The study showed that small and dense low-density lipoprotein (sdLDL) changes were associated with the progression of cerebral small vessel disease (CSVD) in older individuals, and this association was influenced by the Apolipoprotein E (APOE) genotype.

FRONTIERS IN NEUROLOGY (2022)

添加到收藏夹

Review Nutrition & Dietetics

Are Lipid-Lowering and Antihypertensive Medications Used as Complements to Heart-Healthy Diets? A Scoping Review

Clemence Desjardins, Marie Cyrenne-Dussault, Olivier Barbier, Amelie Belanger, Anne Gangloff, Line Guenette, Jacinthe Leclerc, Jean Lefebvre, Arsene Zongo, Jean-Philippe Drouin-Chartier

Summary: This scoping review suggests that the current literature on the relationship between lipid-lowering/antihypertensive medication use and diet provides an incomplete perspective on how medication may influence diet in CVD prevention. Prospective studies assessing intraindividual changes in diet associated with medication initiation and use and how these dynamics influence the CVD risk are thus needed.

ADVANCES IN NUTRITION (2023)

添加到收藏夹

Article Peripheral Vascular Disease

Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trial

Ki-Chul Sung, Jung Hoon Sung, Eun Joo Cho, Jeong Cheon Ahn, Seung Hwan Han, Weon Kim, Kye Hun Kim, Il Suk Sohn, Jinho Shin, Seok Yeon Kim, Kwang-il Kim, Seok Min Kang, Sung-Ji Park, Yong-Jin Kim, Joon-Han Shin, Seong-Mi Park, Chang-Gyu Park

Summary: This clinical trial assessed the efficacy and safety of low-dose triple combinations of amlodipine, telmisartan, and chlorthalidone in patients with essential hypertension. The results showed that this combination treatment effectively lowered blood pressure in patients over an 8-week period without any safety concerns.

JOURNAL OF CLINICAL HYPERTENSION (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Elevation of Hemoglobin A1c Increases the Atherosclerotic Plaque Vulnerability and the Visit-to-Visit Variability of Lipid Profiles in Patients Who Underwent Elective Percutaneous Coronary Intervention

Duanbin Li, Ya Li, Cao Wang, Hangpan Jiang, Liding Zhao, Xulin Hong, Maoning Lin, Yi Luan, Xiaohua Shen, Zhaoyang Chen, Wenbin Zhang

Summary: This study aimed to investigate the influence of elevated glycated hemoglobin A1c (HbA1c) on plaque vulnerability and lipid variability. The results showed that elevated HbA1c was associated with thinner plaque fibrous cap, increased lipid index, and higher macrophage index. This association was also observed in non-diabetic patients. Moreover, elevated HbA1c levels increased the variability of lipid profiles.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

添加到收藏夹

Article Geriatrics & Gerontology

Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging

Bowen Tang, Xia Li, Yunzhang Wang, Arvid Sjolander, Kristina Johnell, Madhav Thambisetty, Luigi Ferrucci, Chandra A. Reynolds, Deborah Finkel, Juulia Jylhava, Nancy L. Pedersen, Sara Hagg

Summary: This study examined the effects of antihypertensive, lipid-lowering, and antidiabetic drugs on biological aging. The results showed that the use of calcium channel blockers was associated with a decrease in DNA-methylation age and functional biological age. However, the effects of other drug subcategories were inconsistent.

GEROSCIENCE (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Antihypertensive drug class in combination with lipid lowering treatment for primary prevention of cardiovascular disease in the elderly

Zhen Zhou, Enayet K. Chowdhury, Monique Breslin, Andrea J. Curtis, Christopher M. Reid, Mark Nelson

Summary: This study of 648 LLT elderly patients free of cardiovascular disease found no significant difference in clinical outcomes between the LLT+ACE-I and LLT+diuretic combinations. The results suggest the need for more randomized trials to provide conclusive evidence.

HEART & LUNG (2022)

添加到收藏夹

Article Peripheral Vascular Disease

Correlations Among Visit-to-Visit Blood Pressure Variability and Treatment With Antihypertensive Medication With Long-Term Adverse Outcomes in a Large Veteran Cohort

Marc D. Basson, William E. Newman, Marilyn G. Klug

Summary: The study found that the possible deleterious effects of thiazides should be considered within the context of the study population, while CCBs may ameliorate BPV over time, but this study does not support choosing CCB over other agents specifically to lessen BPV-associated risk.

AMERICAN JOURNAL OF HYPERTENSION (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Antihypertensive and lipid-lowering drugs usage after primary stroke in a large representative sample of the French population

Julia Perrier, Valerie Olie, Amelie Gabet, Christophe Tzourio, Julien Bezin

Summary: The study aimed to describe the use of antihypertensive and lipid-lowering drugs in post-stroke secondary prevention in France. The findings revealed suboptimal therapeutic management after stroke, particularly regarding lipid-lowering drugs. Patients already being treated showed higher adherence and persistence compared to newly treated patients.

FUNDAMENTAL & CLINICAL PHARMACOLOGY (2022)

添加到收藏夹

Article Oncology

Visit-to-visit variability of lipid and cardiovascular events in patients with familial hypercholesterolemia

Ye-Xuan Cao, Liang Li, Hui-Wen Zhang, Jing-Lu Jin, Hui-Hui Liu, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Qian Dong, Rui-Xia Xu, Jing Sun, Jian-Jun Li

Summary: This study found that variability in lipoprotein (a) (Lp(a)) was associated with major adverse cardiovascular events (MACEs) in patients with familial hypercholesterolemia (FH). Particularly, Lp(a) variability independently predicted MACEs, emphasizing the importance of regular lipid monitoring in high-risk patients.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Peripheral Vascular Disease

Effects of chlorthalidone plus amiloride compared with amlodipine on short-term blood pressure variability in individuals with hypertension and obstructive sleep apnea: a randomized controlled trial

Marcelo B. Lucca, Juliano A. Jorge, Fabio T. Cichelero, Denis Martinez, Rogerio B. Borges, Vania N. Hirakata, Flavio D. Fuchs, Sandra C. Fuchs

Summary: This study compared the effects of chlortalidone plus amiloride and amlodipine on blood pressure variability in patients with hypertension and obstructive sleep apnea syndrome. The results showed that both treatment options had similar effects on short-term blood pressure variability.

BLOOD PRESSURE MONITORING (2023)

添加到收藏夹

Article Physiology

Comparison of antihypertensive drugs amlodipine and perindopril on blood pressure variability after long-term treatment of hypertension induced by apatinib and bevacizumab

Weichao Zhao, Lanbo Liu, Liqiang Chen

Summary: The study aimed to analyze the therapeutic effects of different antihypertensive drugs (amlodipine and perindopril) on hypertension induced by apatinib and bevacizumab. The results showed that amlodipine had a slightly better effect on systolic blood pressure (SBP) and diastolic blood pressure (DBP) variability compared to perindopril, but perindopril had a better effect on improving endothelial function and echocardiographic data.

CHINESE JOURNAL OF PHYSIOLOGY (2023)

添加到收藏夹

Article Clinical Neurology

The EffecTs of Amlodipine and other Blood PREssure Lowering Agents on Microvascular FuncTion in Small Vessel Diseases (TREAT-SVDs) trial: Study protocol for a randomised crossover trial

Anna Kopczak, Michael S. Stringer, Hilde van den Brink, Danielle Kerkhofs, Gordon W. Blair, Maud van Dinther, Laurien Onkenhout, Karolina A. Wartolowska, Michael J. Thrippleton, Marco Duering, Julie Staals, Martin Middeke, Elisabeth Andre, Bo Norrving, Marie-Germaine Bousser, Ulrich Mansmann, Peter M. Rothwell, Fergus N. Doubal, Robert van Oostenbrugge, Geert Jan Biessels, Alastair J. S. Webb, Joanna M. Wardlaw, Martin Dichgans

Summary: This study aims to compare the effects of amlodipine with either losartan or atenolol on microvascular function in patients with symptomatic cerebral small vessel diseases. The study design is a prospective, randomized crossover trial conducted at five study sites across Europe. The primary outcome measure is cerebrovascular reactivity as determined by blood oxygen level dependent brain MRI signal response to hypercapnic challenge. This study provides insights into the effects of different antihypertensive drugs on microvascular function in patients with symptomatic small vessel diseases.

EUROPEAN STROKE JOURNAL (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19

V. Podzolkov, A. Tarzimanova

Summary: Post-COVID-19 syndrome, with a prevalence of over 30% among patients who have had COVID-19, can lead to cardiovascular system damage through various mechanisms. The use of a single pill combination of antihypertensive and statin drugs shows promise in reducing cardiovascular risk and preventing complications in patients who have suffered from a new coronavirus infection.

RATIONAL PHARMACOTHERAPY IN CARDIOLOGY (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Association between visit-to-visit variability of glycemic indices and lipid profile and the incidence of coronary heart disease in adults with type 2 diabetes

Fatemeh Moosaie, Marjan Mouodi, Ali Sheikhy, Aida Fallahzadeh, Niloofar Deravi, Soghra Rabizadeh, Seyede Marzie Fatemi Abhari, Alipasha Meysamie, Fatemeh Dehghani Firouzabadi, Manouchehr Nakhjavani, Alireza Esteghamati

Summary: The study revealed that the variability of glycemic indices in patients with type 2 diabetes is associated with the incidence of coronary heart disease, independent of baseline and mean values.

JOURNAL OF DIABETES AND METABOLIC DISORDERS (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Polypharmacy in Older Adults Hospitalized for Heart Failure

Ozan Unlu, Emily B. Levitan, Evgeniya Reshetnyak, Jerard Kneifati-Hayek, Ivan Diaz, Alexi Archambault, Ligong Chen, Joseph T. Hanlon, Mathew S. Maurer, Monika M. Safford, Mark S. Lachs, Parag Goyal

CIRCULATION-HEART FAILURE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Frailty and Post-hospitalization Outcomes in Patients With Heart Failure With Preserved Ejection Fraction

Parag Goyal, Brian Yum, Pedram Navid, Ligong Chen, Dae H. Kim, Jason Roh, Byron C. Jaeger, Emily B. Levitan

Summary: The study aimed to identify and rank the importance of comorbid conditions associated with post-hospitalization outcomes of HFpEF patients. Age and frailty were found to be the most important predictors for mortality, while frailty was also crucial for predicting rehospitalization and the composite outcome of mortality or all-cause rehospitalization. Frailty was identified as a significant predictor of mortality and rehospitalization in older adults with HFpEF.

AMERICAN JOURNAL OF CARDIOLOGY (2021)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Response by Unlu et al to Letter Regarding Article, Polypharmacy in Older Adults Hospitalized for Heart Failure

Ozan Unlu, Emily B. Levitan, Mathew S. Maurer, Monika M. Safford, Mark S. Lachs, Parag Goyal

CIRCULATION-HEART FAILURE (2021)

添加到收藏夹

Article Medicine, General & Internal

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease

W. S. Jones, H. Mulder, L. M. Wruck, M. J. Pencina, S. Kripalani, D. Munoz, D. L. Crenshaw, M. B. Effron, R. N. Re, K. Gupta, R. D. Anderson, C. J. Pepine, E. M. Handberg, B. R. Manning, S. K. Jain, S. Girotra, D. Riley, D. A. DeWalt, J. Whittle, Y. H. Goldberg, V. L. Roger, R. Hess, C. P. Benziger, P. Farrehi, L. Zhou, D. E. Ford, K. Haynes, J. J. VanWormer, K. U. Knowlton, J. L. Kraschnewski, T. S. Polonsky, D. J. Fintel, F. S. Ahmad, J. C. McClay, J. R. Campbell, D. S. Bell, G. C. Fonarow, S. M. Bradley, A. Paranjape, M. T. Roe, H. R. Robertson, L. H. Curtis, A. G. Sharlow, L. G. Berdan, B. G. Hammill, D. F. Harris, L. G. Qualls, G. Marquis-Gravel, M. F. Modrow, G. M. Marcus, T. W. Carton, E. Nauman, L. R. Waitman, A. M. Kho, E. A. Shenkman, K. M. McTigue, R. Kaushal, F. A. Masoudi, E. M. Antman, D. R. Davidson, K. Edgley, J. G. Merritt, L. S. Brown, D. N. Zemon, T. E. McCormick, J. D. Alikhaani, K. C. Gregoire, R. L. Rothman, R. A. Harrington, A. F. Hernandez

Summary: In a pragmatic trial involving patients with established cardiovascular disease, no significant differences were found in cardiovascular events or major bleeding between patients assigned to daily 81 mg and those assigned to 325 mg of aspirin.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Health care experiences during the COVID-19 pandemic by race and social determinants of health among adults age ≥ 58 years in the REGARDS study

Emily B. Levitan, Virginia J. Howard, Mary Cushman, Suzanne E. Judd, Stephanie E. Tison, Ya Yuan, Debora Kamin Mukaz, Henry E. Wang, Nathalie Pamir, Timothy B. Plante, Stephen P. Juraschek, Monika M. Safford, Parag Goyal

Summary: This study conducted a telephone survey among 9492 Black and White participants in the US to describe their healthcare experiences during the COVID-19 pandemic, revealing that many participants with COVID-19 symptoms or in need of testing did not receive COVID-19 testing.

BMC PUBLIC HEALTH (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Social Determinants of Health and 30-Day Readmissions Among Adults Hospitalized for Heart Failure in the REGARDS Study

Madeline R. Sterling, Joanna Bryan Ringel, Laura C. Pinheiro, Monika M. Safford, Emily B. Levitan, Erica Phillips, Todd M. Brown, Oanh K. Nguyen, Parag Goyal

Summary: The study found no association between social determinants of health and 30-day readmission after a heart failure hospitalization among older adults. Interventions targeting individual social determinants may not be sufficient to prevent readmissions in this population.

CIRCULATION-HEART FAILURE (2022)

添加到收藏夹

Article Health Care Sciences & Services

Engaging veteran stakeholders to identify patient-centred research priorities for optimizing implementation of lung cancer screening

Alice Yan, Katinka Hooyer, Onur Asan, Mark Flower, Jeff Whittle

Summary: Collaboration between Veteran patients and stakeholders led to the development of a research agenda for LDCT screening, with prioritized research questions focused on insurance impact, Veteran education, screening result follow-up, suggesting the importance of patient engagement in research priorities.

HEALTH EXPECTATIONS (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Sacubitril/Valsartan Initiation Among Veterans Who Are Renin-Angiotensin-Aldosterone System Inhibitor Naive With Heart Failure and Reduced Ejection Fraction

April F. Mohanty, Emily B. Levitan, Jordan B. King, John A. Dodson, Orly Vardeny, James Cook, Jennifer S. Herrick, Tao He, Olga Patterson, Patrick R. Alba, Patricia A. Russo, Engels N. Obi, Michelle E. Choi, James C. Fang, Adam P. Bress

Summary: The initiation rate of sacubitril/valsartan for HFrEF patients in the Veterans Administration increased gradually in the 4 years following the approval by the FDA. Compared with ACEI or ARB initiators, those initiating sacubitril/valsartan had fewer baseline cardiovascular comorbidities and the lowest proportion achieving >= 50% target daily dose at the 6-month follow-up. Identifying reasons for the lower follow-up dosing of sacubitril/valsartan could aid in supporting guideline recommendations and quality improvement strategies for HFrEF patients.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Depressive Symptoms and Incident Hospitalization for Heart Failure: Findings From the REGARDS Study

Yulia Khodneva, Parag Goyal, Emily B. Levitan, Elizabeth A. Jackson, Suzanne Oparil, Madeline R. Sterling, Andrea L. Cherrington, Raegan Durant, Monika M. Safford

Summary: This study found an association between depressive symptoms and incident hospitalization for HFpEF, but not for HFrEF or among those with baseline CHD.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Disparities in Postdischarge Ambulatory Care Follow-Up Among Medicaid Beneficiaries With Diabetes, Hospitalized for Heart Failure

Yulia Khodneva, Emily B. Levitan, Pankaj Arora, Caroline A. Presley, Suzanne Oparil, Andrea L. Cherrington

Summary: This study examined the ambulatory follow-up of patients with comorbid diabetes and heart failure after hospital discharge. The results showed that more than half of the patients did not receive guideline-concordant postdischarge care. Non-White and Hispanic/Other patients were less likely to receive recommended postdischarge care.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

添加到收藏夹

Article Immunology

Geospatial Analysis of Time to Human Immunodeficiency Virus (HIV) Diagnosis and Adult HIV Testing Coverage Highlights Areas for Intervention in the US Southeast

Lynn T. Matthews, Dustin M. Long, John Bassler, Ariann Nassel, Emily B. Levitan, Sonya L. Heath, Jeremiah Rastegar, Madeline C. Pratt, Mirjam-Collette Kempf

Summary: By combining public health surveillance with commercial testing data, we can gain a more nuanced understanding of HIV testing gaps in a rural HIV epidemic state and identify areas to prioritize for testing outreach.

OPEN FORUM INFECTIOUS DISEASES (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors

Saket Girotra, Amanda Stebbins, Lisa Wruck, Guillaume Marquis-Gravel, Kamal Gupta, Peter Farrehi, Catherine P. Benziger, Mark B. Effron, Jeffrey Whittle, Daniel Munoz, Sunil Kripalani, David Anderson, Sandeep K. Jain, Tamar S. Polonsky, Faraz S. Ahmad, Matthew T. Roe, Russell L. Rothman, Robert A. Harrington, Adrian F. Hernandez, W. Schuyler Jones

Summary: This study found that baseline use of P2Y12 inhibitors did not modify the relative effectiveness and safety of high- versus low-dose aspirin.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

添加到收藏夹

Article Health Care Sciences & Services

A Veteran-Centric Web-Based Decision Aid for Lung Cancer Screening: Usability Analysis

Marilyn M. Schapira, Sumedha Chhatre, Jason M. Prigge, Jessica Meline, Dana Kaminstein, Keri L. Rodriguez, Liana Fraenkel, Jeffrey D. Kravetz, Jeff Whittle, Lori A. Bastian, Anil Vachani, Scott Akers, Susan Schrand, Jennifer Ibarra, Onur Asan

Summary: This study conducted usability testing of an LCS decision tool designed for veterans receiving care at a Veteran Affairs medical center. The results showed that the tool had good usability and could help veterans understand lung cancer screening and prepare for shared decision-making.

JMIR FORMATIVE RESEARCH (2022)

添加到收藏夹

Article Medicine, General & Internal

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease

W. Schuyler Jones, Hillary Mulder, Lisa M. Wruck, Michael J. Pencina, Sunil Kripalani, Daniel Munoz, David L. Crenshaw, Mark B. Effron, Richard N. Re, Kamal Gupta, R. David Anderson, Carl J. Pepine, Eileen M. Handberg, Brittney R. Manning, Sandeep K. Jain, Saket Girotra, Danielle Riley, Darren A. DeWalt, Jeff Whittle, Ythan H. Goldberg, Veronique L. Roger, Rachel Hess, Catherine P. Benziger, Peter Farrehi, Li Zhou, Daniel E. Ford, Kevin Haynes, Jeffrey J. VanWormer, Kirk U. Knowlton, Jennifer L. Kraschnewski, Tamar S. Polonsky, Dan J. Fintel, Faraz S. Ahmad, James C. McClay, James R. Campbell, Douglas S. Bell, Gregg C. Fonarow, Steven M. Bradley, Anuradha Paranjape, Matthew T. Roe, Holly R. Robertson, Lesley H. Curtis, Amber G. Sharlow, Lisa G. Berdan, Bradley G. Hammill, Debra F. Harris, Laura G. Qualls, Guillaume Marquis-Gravel, Madelaine F. Modrow, Gregory M. Marcus, Thomas W. Carton, Elizabeth Nauman, Lemuel R. Waitman, Abel N. Kho, Elizabeth A. Shenkman, Kathleen M. McTigue, Rainu Kaushal, Frederick A. Masoudi, Elliott M. Antman, Desiree R. Davidson, Kevin Edgley, James G. Merritt, Linda S. Brown, Doris N. Zemon, Thomas E. McCormick, Jacqueline D. Alikhaani, Kenneth C. Gregoire, Russell L. Rothman, Robert A. Harrington, Adrian F. Hernandez

Summary: In an open-label, pragmatic trial, patients with cardiovascular disease were randomly assigned to a strategy of 81 mg or 325 mg of aspirin daily. A substantial proportion of those assigned to the 325-mg dose switched to the 81-mg dose, and there were no significant differences in cardiovascular events or major bleeding between the two groups.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Geriatrics & Gerontology

Influence of mid-life cognitive activity on cognitive function among men aged 68 years or older

Allison Cotter, Jessica Kim, Kia Semons-Booker, Kate Sherman, Rodney Sparapani, Jeff Whittle

Summary: The study found that midlife cognitive activity was associated with late-life cognitive activity, but did not impact cognitive function or overall function. Adjusted analyses yielded similar results. However, using more comprehensive measures of cognitive activity may better detect such an association.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2021)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.